Catalyst Pharmaceuticals Inc header image

Catalyst Pharmaceuticals Inc

CPRX

Equity

ISIN null / Valor 2649177

NASDAQ (2026-05-01)

USD 28.74+2.17%

Catalyst Pharmaceuticals Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Catalyst Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company that specializes in the in-licensing, development, and commercialization of innovative treatments for patients with rare diseases. The company's primary focus is on addressing unmet medical needs by bringing novel therapeutic options to market. Catalyst Pharmaceuticals leverages its expertise in drug development and regulatory processes to advance its pipeline of products, aiming to improve the quality of life for individuals affected by rare and debilitating conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

18.4%1Y

69.7%3Y

528%5Y

Performance

35.1%1Y

41.7%3Y

48.6%5Y

Volatility

3510 M

Market cap (USD)

1,417,804

Daily traded volume (Shares)

21.34 / 20.93

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc Valor: 24511852

Annual Return

-50%0%+50%

Risk level

110

-0.36%USD 21.88

Schrodinger Inc

Schrodinger Inc Valor: 51947209

Annual Return

-50%0%+50%

Risk level

110

3.60%USD 12.39

MannKind Corp

MannKind Corp Valor: 35935511

Annual Return

-50%0%+50%

Risk level

110

0.35%USD 2.84

Outset Medical Inc

Outset Medical Inc Valor: 56717137

Annual Return

-50%0%+50%

Risk level

110

2.11%USD 4.36

BridgeBio Pharma Inc

BridgeBio Pharma Inc Valor: 48204826

Annual Return

-50%0%+50%

Risk level

110

-3.59%USD 68.56

Protagonist Therapeutics Inc

Protagonist Therapeutics Inc Valor: 33278818

Annual Return

-50%0%+50%

Risk level

110

-0.61%USD 98.37

Allogene Therapeutics Inc

Allogene Therapeutics Inc Valor: 43756548

Annual Return

-50%0%+50%

Risk level

110

0.94%USD 2.15

Summit Therapeutics Inc

Summit Therapeutics Inc Valor: 56903013

Annual Return

-50%0%+50%

Risk level

110

-24.91%USD 16.11

Glaukos Corp

Glaukos Corp Valor: 28262610

Annual Return

-50%0%+50%

Risk level

110

-2.40%USD 140.22

Stryker Corp

Stryker Corp Valor: 974330

Annual Return

-50%0%+50%

Risk level

110

-6.47%USD 294.73

SIX

FactSet

Clearbit

Logos provided by Clearbit